Citation Impact
Citing Papers
Impairment of starvation-induced and constitutive autophagy in Atg7 -deficient mice
2005 StandoutNobel
C-terminal region of activation-induced cytidine deaminase (AID) is required for efficient class switch recombination and gene conversion
2014 StandoutNobel
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
Molecular mechanisms mediating metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
An integrated encyclopedia of DNA elements in the human genome
2012 StandoutNature
Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases
2016 StandoutNobel
The RB and p53 pathways in cancer
2002 Standout
Ferroptosis as a p53-mediated activity during tumour suppression
2015 StandoutNature
Cell-cycle checkpoints and cancer
2004 StandoutNature
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Apoptosis by Death Factor
1997 Standout
The x cystine/glutamate antiporter: A potential target for therapy of cancer and other diseases
2008
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
2013 StandoutNobel
Cancer gene therapy: fringe or cutting edge?
2001
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
1992 StandoutNature
Targeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytes
2020
ESDN, a Novel Neuropilin-like Membrane Protein Cloned from Vascular Cells with the Longest Secretory Signal Sequence among Eukaryotes, Is Up-regulated after Vascular Injury
2001 StandoutNobel
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
Nanoporous Carbohydrate Metal–Organic Frameworks
2011 StandoutNobel
The autophagosomal–lysosomal compartment in programmed cell death
2001
Four-and-a-Half LIM Domain Proteins Inhibit Transactivation by Hypoxia-inducible Factor 1
2012 StandoutNobel
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
2016 StandoutNobel
Functional Interaction between the Mouse Notch1 Intracellular Region and Histone Acetyltransferases PCAF and GCN5
2000 StandoutNobel
Control of metastatic progression by microRNA regulatory networks
2013
Strategies for immunotherapy of cancer
2000
Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses
2016
EMT: 2016
2016 Standout
Transgenic T cell receptor interactions in the lymphoproliferative and autoimmune syndromes of lpr and gld mutant mice
1992
Oncolytic viruses: adenoviruses
2017
The Fas Death Factor
1995 StandoutScience
Cyclodextrin-based pharmaceutics: past, present and future
2004 Standout
Sulfasalazine-Induced Reduction of Glutathione Levels in Breast Cancer Cells: Enhancement of Growth-Inhibitory Activity of Doxorubicin
2007
Histone acetylation in chromatin structure and transcription
1997 StandoutNature
Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives
2014
Adipocyte Inflammation Is Essential for Healthy Adipose Tissue Expansion and Remodeling
2014
Metastatic colonization by circulating tumour cells
2016 StandoutNature
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
1996 Standout
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Repair of and checkpoint response to topoisomerase I-mediated DNA damage
2003
Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents
2002
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
2012 StandoutNobel
A novel TNF-inducible message with putative growth suppressor function
1999
Regulation of epithelial–mesenchymal and mesenchymal–epithelial transitions by microRNAs
2013
Convergence of Wnt, ß-Catenin, and Cadherin Pathways
2004 StandoutScience
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
CBP/p300 in cell growth, transformation, and development
2000
Physiology meets biophysics: Visualizing the interaction of hypoxia-inducible factor 1α with p300 and CBP
2002 StandoutNobel
Perspective on Adenoviruses: Epidemiology, Pathogenicity, and Gene Therapy
2019
Cytotoxicity of fresh NK1.1+ T cell receptor alpha/beta+ thymocytes against a CD4+8+ thymocyte population associated with intact Fas antigen expression on the target.
1994
Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
1996 StandoutScience
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
2015 StandoutNobel
Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
2011 StandoutNobel
Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene.
1993
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
Antiviral Actions of Interferons
2001 Standout
Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses
2001 StandoutNobel
Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice.
1994
CD4dull+ hematopoietic progenitor cells in murine bone marrow
1993
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Viral Subversion of the Immune System
2000
Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
2012 StandoutNobel
Methylation of hypoxia-inducible factor (HIF)-1α by G9a/GLP inhibits HIF-1 transcriptional activity and cell migration
2018 StandoutNobel
Transgenic rearranged T cell receptor gene inhibits lymphadenopathy and accumulation of CD4-CD8-B220+ T cells in lpr/lpr mice.
1990
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
APE1 is dispensable for S-region cleavage but required for its repair in class switch recombination
2014 StandoutNobel
E3 ubiquitin ligase Mindbomb 1 facilitates nuclear delivery of adenovirus genomes
2020 StandoutNobel
CD1 Recognition by Mouse NK1 + T Lymphocytes
1995 StandoutScience
Works of Károly Tóth being referenced
Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition
2012
Endometrial safety and tolerability of AERODIOL® (intranasal estradiol) for 1 year
2000
Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1α
2010
FUNCTIONS AND MECHANISMS OF ACTION OF THE ADENOVIRUS E3 PROTEINS
2004
Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic
1999
Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells
1998 NatureNobel
Dose-ranging studies of a novel intranasal estrogen replacement therapy
2001
Transcriptional Repression by Human Adenovirus E1A N Terminus/Conserved Domain 1 Polypeptides in Vivo and in Vitro in the Absence of Protein Synthesis
1995
Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
2014
Induction of Biphasic DNA Double Strand Breaks and Activation of Multiple Repair Protein Complexes by DNA Topoisomerase I Drug 7-Ethyl-10-hydroxy-camptothecin
2002
DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux
1996
Immunosuppression Enhances Oncolytic Adenovirus Replication and Antitumor Efficacy in the Syrian Hamster Model
2008
An Oncolytic Adenovirus Vector Combining Enhanced Cell-to-Cell Spreading, Mediated by the ADP Cytolytic Protein, with Selective Replication in Cancer Cells with Deregulated Wnt Signaling
2004
Tissue-Specific, Tumor-Selective, Replication-Competent Adenovirus Vector for Cancer Gene Therapy
2001
miRNA-29b Suppresses Prostate Cancer Metastasis by Regulating Epithelial–Mesenchymal Transition Signaling
2012
Altered expression of self-reactive T cell receptor Vbeta regions in autoimmune mice.
1990
Syrian Hamster as a Permissive Immunocompetent Animal Model for the Study of Oncolytic Adenovirus Vectors
2006
Tumor-Specific, Replication-Competent Adenovirus Vectors Overexpressing the Adenovirus Death Protein
2000
Transcription factor TFIID is a direct functional target of the adenovirus E1A transcription-repression domain.
1995
d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors.
1996
Therapeutic Synergy Between Irinotecan and 5-Fluorouracil against Human Tumor Xenografts
2004